Skip to main content

Peer Review reports

From: Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review

Original Submission
29 Jul 2023 Submitted Original manuscript
29 Oct 2023 Reviewed Reviewer Report
10 Nov 2023 Reviewed Reviewer Report
22 Nov 2023 Author responded Author comments - Yu Zheng
23 Nov 2023 Author responded Author comments - Yu Zheng
Resubmission - Version 2
22 Nov 2023 Submitted Manuscript version 2
23 Nov 2023 Author responded Author comments - Yu Zheng
Resubmission - Version 3
23 Nov 2023 Submitted Manuscript version 3
18 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
18 Dec 2023 Editorially accepted
8 Jan 2024 Article published 10.1186/s12877-023-04625-3

You can find further information about peer review here.

Back to article page